April 23, 2024

BeLAB21/22 BRIDGE

BeLAB21/22 BRIDGE

Mediated and supported by bioRN, Evotec established in 2021 the beLAB2122 BRIDGE. With 20M Euro Fund for preclinical development of academic drug discovery projects, beLAB2122 is a new public-private partnership between the leading academic institutions of the Rhine-Neckar region, Evotec and Bristol Myers Squibb to identify, fund and execute novel disease modifying therapeutic projects with the goal to develop these to new spinout companies.

tester

Our latest News

discover more
Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026

Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026

More Information HEIDELBERG, Germany, September 30, 2026 – Hummingbird Diagnostics GmbH, a molecular diagnostics company specializing in blood-based small RNA analysis for precision oncology, today announced that data from a new collaborative study will be presented at the ESMO Congress 2026 in Madrid, Spain. Building on Hummingbird’s expertise in early cancer detection, the study explores […]

Greater Precision and Safety in Neurosurgical Procedures

Greater Precision and Safety in Neurosurgical Procedures

A new surgical system at the Department of Neurosurgery at Heidelberg University Hospital helps surgeons precisely plan procedures on the brain, spine, and skull base, monitor them during surgery, and perform them with millimeter precision. The “Robotic Surgery Suite,” which cost approximately 1.6 million euros, combines live imaging, digital navigation, and robotic assistance directly in […]

Mitochondrial Protein Complexes: A Single Amino Acid Can Jeopardize Their Stability

Mitochondrial Protein Complexes: A Single Amino Acid Can Jeopardize Their Stability

Scientists from Heidelberg and Freiburg identify the mechanism by which proteins assemble into stable complexes in mitochondria A tiny processing step has far-reaching consequences for mitochondrial function: The removal of a single amino acid determines whether new proteins can assemble into stable complexes within these cellular powerhouses. This process is carried out by a specific […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp